Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8
- Authors
- Hatcher, John M.; Wang, Eric S.; Johannessen, Liv; Kwiatkowski, Nicholas; Sim, Taebo; Gray, Nathanael S.
- Issue Date
- 2018-06
- Publisher
- AMER CHEMICAL SOC
- Citation
- ACS MEDICINAL CHEMISTRY LETTERS, v.9, no.6, pp.540 - 545
- Abstract
- Cortistatin A is a natural product isolated from the marine sponge Corticium simplex and was found to be a potent and selective inhibitor of CDK8. Many synthetic groups have reported total syntheses of Cortistatin A; however, these syntheses require between 16 and 30 steps and report between 0.012-2% overall yields, which is not amenable to large-scale production. Owing to similarities between the complex core of Cortistatin A and the simple steroid core, we initiated a campaign to design simple, more easily prepared CDK8 inhibitors based on a steroid scaffold that would be more convenient for large-scale synthesis. Herein, we report the discovery and optimization of JH-VIII-49, a potent and selective inhibitor of CDK8 with a simple steroid core that has an eight-step synthesis with a 33% overall yield, making it suitable for large-scale preparation. Using this scaffold, we then developed a bivalent small molecule degrader, JH-XI-10-02, that can recruit the E3 ligase CRL4(cerebion) to promote the ubiquitination and proteosomal degradation of CDK8.
- Keywords
- MEDIATOR COMPLEX; KINASE; TRANSCRIPTION; CORTISTATIN; GENES; DEGRADATION; ELONGATION; ACTIVATION; SRB10/CDK8; TURNOVER; MEDIATOR COMPLEX; KINASE; TRANSCRIPTION; CORTISTATIN; GENES; DEGRADATION; ELONGATION; ACTIVATION; SRB10/CDK8; TURNOVER; CDK8; CDK19; Cortistatin A; kinase inhibitor; mediator complex; PROTAC; Cereblon; E3 ligase; degradation
- ISSN
- 1948-5875
- URI
- https://pubs.kist.re.kr/handle/201004/121320
- DOI
- 10.1021/acsmedchemlett.8b00011
- Appears in Collections:
- KIST Article > 2018
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.